Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-10-17
1994-08-02
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546122, 546174, 546172, 546176, 514314, 514405, 514415, 514419, 548360, 548470, 548493, C07D40106, C07D47104, C07D24700, C07D20912, A61K 3140, A61K311415
Patent
active
053345975
ABSTRACT:
Compounds having the formula I: ##STR1## are antagonists of the actions of leukotrienes. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection.
REFERENCES:
Matassa, et al., J. Med. Chem., 33, 1781-1790 (1990).
Blouin Marc
Prasit Petpiboon
Daniel Mark R.
Merck Frosst Canada Inc.
Springer David B.
Yang Mollie M.
LandOfFree
Indole carbamates as leukotriene antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indole carbamates as leukotriene antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole carbamates as leukotriene antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-64987